Hassan developed his scientific skills and knowledge at Durham, primarily in molecular biology and fusion proteins. He has also worked at the birthplace of the CRISPR-Cas9 technology, Vienna Biocenter, looking at the role of transcription factors in stem cell differentiation during early embryonic development. He developed his interest in startups while working as one of the first employees for a leading start-up in Newcastle. He has also previously founded a venture-backed tech startup and prior to joining UKI2S, he worked as a start-up scout for Ada Ventures.
Hassan is responsible for screening new investment opportunities, completing initial diligence for promising opportunities, and portfolio support and monitoring, with a specific focus on engineering biology investments.